Topical corticosteroids for atopic eczema: clinical and cost effectiveness of once-daily vs. more frequent use.

Author: ColquittJ L, DavidsonP, GreenC, KirbyJ

Paper Details 
Original Abstract of the Article :
BACKGROUND: Topical corticosteroids remain the mainstay of treatment for atopic eczema, yet there is uncertainty over the frequency of their use in terms of clinical and cost effectiveness. OBJECTIVES: To assess the clinical and cost effectiveness of once-daily vs. more frequent use of same-potency...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://doi.org/10.1111/j.1365-2133.2005.06410.x

データ提供:米国国立医学図書館(NLM)

Topical Corticosteroids: Frequency of Application for Atopic Eczema

The study delves into the optimal frequency of application for topical corticosteroids in the management of atopic eczema, a common inflammatory skin condition. Researchers investigated the clinical and cost-effectiveness of once-daily versus more frequent application of corticosteroids in patients with atopic eczema. Their findings suggest that there may be little difference in clinical outcomes between these two approaches.

Exploring the Effectiveness of Different Application Frequencies

The study found that there was no clear evidence to favor either once-daily or more frequent application of topical corticosteroids for atopic eczema. While some studies suggested a slight advantage for twice-daily treatment, the overall findings did not support a definitive preference for one frequency over the other. It's like choosing between two trails in the desert, both lead to the destination but one might be slightly more direct.

Optimizing Treatment Decisions for Atopic Eczema

The study highlights the importance of individualizing treatment decisions for patients with atopic eczema. While there is no clear evidence to support one frequency of application over another, clinicians should consider factors such as patient preference, severity of eczema, and potential side effects when making treatment decisions. It's like choosing the right camel for a desert journey, individual needs and preferences should guide the selection of treatment strategies.

Dr.Camel's Conclusion

This study provides valuable insights into the use of topical corticosteroids for atopic eczema. While the frequency of application may not significantly affect clinical outcomes, individualized treatment decisions based on patient-specific factors are crucial for optimizing treatment efficacy. Remember, just like a desert explorer needs to adapt their strategy based on the terrain, clinicians should tailor treatment plans for patients with atopic eczema to ensure the best possible outcomes.

Date :
  1. Date Completed 2005-04-14
  2. Date Revised 2022-03-30
Further Info :

Pubmed ID

15656813

DOI: Digital Object Identifier

10.1111/j.1365-2133.2005.06410.x

Related Literature

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.